Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

KLRAKailera Therapeutics, Inc.

Nasdaq · CIK 0002096997
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts145

Identity from submissions API

NameKailera Therapeutics, Inc.
CIK0002096997
TickersKLRA
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone508-440-9475
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
180 THIRD AVENUE
4TH FLOOR
WALTHAM
MA
02451
MA
Mailing address
180 THIRD AVENUE
4TH FLOOR
WALTHAM
MA
02451
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

64 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-04 10-Q 10-Q 0001193125-26-447257 001-43233 261522327 34 13385432 1 1
2026-11-04 8-K 8-K 2.02,9.01 0001193125-26-447232 001-43233 261522217 34 388567 1 1
2026-09-09 4 4 0001193125-26-386782 5493
2026-09-09 3 3 0001193125-26-386778 26232
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352133 005-95629 261280887 34 18016
2026-08-14 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000151 005-95629 261276262 34 12577
2026-08-12 10-Q 10-Q 0001193125-26-346958 001-43233 261267957 34 12525424 1 1
2026-08-12 8-K 8-K 2.02,9.01 0001193125-26-346919 001-43233 261267809 34 411432 1 1
2026-08-05 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-090642 005-95629 261241133 34 7837
2026-07-08 4 4 0001193125-26-298558 5558
2026-07-08 3 3 0001193125-26-298547 22683
2026-06-11 4 4 0001193125-26-267493 6906
2026-05-26 10-Q 10-Q 0001193125-26-239417 001-43233 261020337 34 9589582 1 1
2026-05-26 8-K 8-K 2.02,9.01 0001193125-26-239362 001-43233 261020115 34 375081 1 1
2026-04-23 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-174330 005-95629 26890128 34 203984
2026-04-23 SCHEDULE 13D xslSCHEDULE_13D_X02/primary_doc.xml 0001193125-26-174293 005-95629 26890100 34 405961
2026-04-22 4 xslF345X06/form4-04222026_040401.xml 0001231919-26-000390 13336
2026-04-22 4 OWNERSHIP DOCUMENT 0001104659-26-046276 12844
2026-04-20 4 4 0001193125-26-164417 26320
2026-04-20 4 4 0001193125-26-164407 15710
2026-04-20 4 4 0001193125-26-164389 31381
2026-04-20 4 4 0001193125-26-164388 11570
2026-04-20 4 4 0001193125-26-164307 8097
2026-04-20 4 4 0001193125-26-164306 8110
2026-04-20 4 4 0001193125-26-164299 8117
2026-04-20 4 4 0001193125-26-164275 8171
2026-04-20 4 4 0001193125-26-164271 5315
2026-04-20 4 4 0001193125-26-164264 8121
2026-04-20 4 4 0001193125-26-164253 5360
2026-04-20 4 4 0001193125-26-164243 8124
2026-04-20 4 4 0001193125-26-164226 5354
2026-04-20 4 4 0001193125-26-164224 5312
2026-04-20 4 4 0001193125-26-164210 8068
2026-04-20 8-K 8-K 5.03,8.01,9.01 0001193125-26-164040 001-43233 26875275 34 404209 1 1
2026-04-17 424B4 424B4 0001193125-26-161521 333-294690 26871566 33 10099740
2026-04-17 S-8 S-8 0001193125-26-160175 333-295117 26869313 33 551796 1 1
2026-04-16 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001217 333-294690 26869298 33 1751
2026-04-16 3 OWNERSHIP DOCUMENT 0001104659-26-044508 7592
2026-04-16 3 3 0001193125-26-159772 6842
2026-04-16 3 3 0001193125-26-159766 23333
2026-04-16 3 3 0001193125-26-159765 25268
2026-04-16 3 3 0001193125-26-159757 5223
2026-04-16 3 3 0001193125-26-159694 25677
2026-04-16 3 3 0001193125-26-159682 25999
2026-04-16 3 3 0001193125-26-159679 24293
2026-04-16 3 3 0001193125-26-159674 24815
2026-04-16 3 xslF345X06/form3-04162026_110446.xml 0001231919-26-000369 8208
2026-04-16 3 3 0001193125-26-159669 23364
2026-04-16 3 3 0001193125-26-159668 22484
2026-04-16 3 3 0001193125-26-159665 24774
2026-04-16 3 3 0001193125-26-159657 26096
2026-04-16 3 3 0001193125-26-159656 30558
2026-04-16 3 3 0001193125-26-159646 23195
2026-04-16 3 3 0001193125-26-159645 25021
2026-04-16 3 3 0001193125-26-159636 24902
2026-04-16 S-1MEF S-1MEF 0001193125-26-159585 333-295114 26868907 33 175787 1 1
2026-04-16 3 3 0001193125-26-159467 7174
2026-04-16 3 FORM 3 0001829126-26-003567 5575
2026-04-15 CERT 2096997_8A_Cert_KLRA.pdf 0001354457-26-000351 001-43233 26863970 34 180632
2026-04-14 8-A12B 8-A12B 0001193125-26-154882 001-43233 26860882 34 13876
2026-04-13 S-1/A S-1/A 0001193125-26-151904 333-294690 26856373 33 11165434 1 1
2026-03-27 S-1 S-1 0001193125-26-128952 333-294690 26807171 33 11783494 1 1
2026-02-11 DRS/A filename1.htm 0001193125-26-046566 377-08841 26620816 33 10864950
2025-12-19 DRS filename1.htm 0001193125-25-326849 377-08841 251587635 33 7761774

Latest XBRL company facts

One latest value per concept from companyfacts (145 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 129.85M 2026-10-29 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
ffd NetFeeAmt NetFeeAmt USD 98,659.43 2026-04-16 S-8 2026-04-17 0001193125-26-160175
ffd TtlFeeAmt TtlFeeAmt USD 98,659.43 2026-04-16 S-8 2026-04-17 0001193125-26-160175
ffd TtlOfferingAmt TtlOfferingAmt USD 714.41M 2026-04-16 S-8 2026-04-17 0001193125-26-160175
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-04-16 S-8 2026-04-17 0001193125-26-160175
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-04-16 S-1MEF 2026-04-16 0001193125-26-159585
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 9.43M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 5.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 31.59M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 3.43M 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346958
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -3.74M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.69B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 9.92M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 22.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 19.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap Assets Assets USD 1.08B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap AssetsCurrent Assets, Current USD 919.76M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 106.54M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 1.04B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 107.30M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 107.30M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -53.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 29.60M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 800.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 129.68M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 129.68M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap CommonStockValue Common Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -289.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ContractualObligation Contractual Obligation USD 15.90M 2025-10-31 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 100.00M 2025-05-08 2026 Q1 10-Q 2026-05-26 0001193125-26-239417
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 103.20M 2025-10-31 2026 Q1 10-Q 2026-05-26 0001193125-26-239417
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 922.50M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Security 144 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 303,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap DividendsCash Dividends, Cash USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.68 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.68 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 11.12M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 92.30M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap FairValueOptionCreditRiskGainsLossesOnAssets Fair Value, Option, Credit Risk, Gains (Losses) on Assets USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-26 0001193125-26-239417
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 55.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 2.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -781,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities Increase (Decrease) in Other Accounts Payable and Accrued Liabilities USD -6.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -2.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -203,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 7.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 26.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap InterestReceivableCurrent Interest Receivable, Current USD 6.26M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap LeaseCost Lease, Cost USD 1.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 14.05M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 2.22M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.34M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.30M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 2.26M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 549,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 4.08M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap LettersOfCreditOutstandingAmount Letters of Credit Outstanding, Amount USD 800,000 2025-10-31 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap Liabilities Liabilities USD 51.06M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.08B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap LiabilitiesCurrent Liabilities, Current USD 42.12M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 794.92M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 136.19M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 663.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -437.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -279.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -285.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 26.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap NumberOfReportableSegments Number of Reportable Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OperatingExpenses Operating Expenses USD 312.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -312.37M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 2.20M 2025-10-31 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 9.97M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.09M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 8.88M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OperatingLeasePayments Operating Lease, Payments USD 1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 9.63M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.12 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.54M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OtherAssetsCurrent Other Assets, Current USD 4.89M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 63,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -3.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 67,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 13,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 79,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-26 0001193125-26-239417
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 211,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 3.04M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-26 0001193125-26-239417
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 6.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 775.32M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap PreferredStockConvertibleSharesIssuable PreferredStockConvertibleSharesIssuable shares 84.60M 2025-12-31 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 18.30M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 1.34M 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346958
us-gaap PrepaidInsurance Prepaid Insurance USD 930,000 2026-06-30 2026 Q2 10-Q 2026-08-12 0001193125-26-346958
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 668.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 337.97M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 826,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 1.65M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 256.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 761,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 761,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -654.50M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 22.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.811 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 23.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 3.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 5.37 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 914,695 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 6.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 67.10M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 19.15M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 9.32 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 5.3 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 8.38 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 15.34 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.03B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 146,869 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 992.36M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 661.98M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 339,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 992.36M 2025-12-31 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap TemporaryEquityLiquidationPreference Temporary Equity, Liquidation Preference USD 959.96M 2025-12-31 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap VariableLeaseCost Variable Lease, Cost USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 77.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 77.69M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001193125-26-447257

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →